CSIMarket


Adc Therapeutics Sa  (ADCT)
Other Ticker:  
 


 

Adc Therapeutics Sa

ADCT's Financial Statements and Analysis



Adc Therapeutics Sa reported in the first quarter of 2024 net loss per share of $-0.56 compare to earnings per share of $0.00 in the same quarter a year ago and improved compare to net loss per share of $-1.82 realized in previous quarter.


first quarter of 2024
Earnings Per Share Revenues
$ -0.56 $  18 Mill
$-0.56     $+18M    



Adc Therapeutics Sa's Revenue rose by 0 % in first quarter of 2024 (Mar 31 2024) year on year, to $18 million and declined by -74.05 % sequentially.


Adc Therapeutics Sa is

More on ADCT's Income Statement



Adc Therapeutics Sa in the first quarter of 2024 recorded net loss of $-46.606 million, compare to net income of $0.000 million achieved in II. Quarter a year ago.

Sequentially net loss narrowed from net loss of $-240.053 million realized in previous quarter.

More on ADCT's Growth

Adc Therapeutics Sa Inventories
In Mar 31 2024 company's net cash and cash equivalents decreased by $-44 million

More on ADCT's Cash flow Statement


Adc Therapeutics Sa does not pay out common stock dividend.

In trailing twelve-month period Adc Therapeutics Sa payed $ -1.97 cash per share, on a free-cash flow basis .


Tangible Book value fell to $ -2.36 per share from $ -1.82.

Company issued 0.90 million shares or 1.10 % in Mar 31 2024.


More on ADCT's Dividends

 Market Capitalization (Millions) 295
 Shares Outstanding (Millions) 83
 Total Debt (Millions $) 113
 Revenue (TTM) (Millions $) 298
 Net Income (TTM) (Millions $) -442
 Cash Flow (TTM) (Millions $) -92
 Capital Exp. (TTM) (Millions $) -4
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 9,050




Adc Therapeutics Sa does not pay out common stock dividend.

In trailing twelve-month period Adc Therapeutics Sa had negative $ -1.97 cash flow per share, on a free-cash flow basis .


Tangible Book value fell to $ -2.36 per share from $ -1.82.

Company issued 0.90 million shares or 1.10 % in Mar 31 2024.


More on ADCT's Balance Sheets

 Market Capitalization (Millions) 295
 Shares Outstanding (Millions) 83
 Total Debt (Millions $) 113
 Revenue (TTM) (Millions $) 298
 Net Income (TTM) (Millions $) -442
 Cash Flow (TTM) (Millions $) -92
 Capital Exp. (TTM) (Millions $) -4
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 9,050
   


  News about Adc Therapeutics Sa Earnings